Voluntary Faculty
Voluntary faculty are typically clinicians or others who are employed outside of the School but make significant contributions to department programs at the medical center or at affiliate institutions.
Voluntary rank detailsMacrene Alexiades-Armenakas, MD, PhD
Associate Clinical ProfessorAbout
Research
Publications
2026
Development of a Core Outcome Domain Set for Facial Aging.
Dirr M, Ahmed A, Schlessinger D, Lazaro-Camp V, Smith S, Gullapalli T, Dragovic D, Chang J, Zhang E, Alam M, Anvery N, Christensen R, Ibrahim S, Kang B, Wong C, Iyengar S, Yanes A, Cotseones J, Ashchyan H, Patel P, Sheikh U, Franklin M, Hanna C, Chiren S, Schmitt J, Furlan K, Alexiades M, Alhusayen R, Alster T, Beer K, Bertucci V, Bloom J, Briceño C, Bucay V, Butterwick K, Hugues C, Casabona G, Connolly K, Cotofana S, Council M, Cox S, Darmanescu M, De Boulle K, Desai S, Donofrio L, Dover J, Draelos Z, Eisen D, El-Domyati M, El-Garem Y, Fischer J, Fitzgerald R, Friedmann D, Galadari H, Gladstone H, Goldman M, Goodman G, Green J, Halachmi S, Hanke C, Humphrey S, Ibrahim S, Jagdeo J, Jiang S, Karen J, Kauvar A, Kibbi A, Kim J, Kim J, de Lacerda D, Lask G, Lopez G, Lupo M, Mariwalla K, Matarasso S, Mekokishvili L, Narins R, Ogilvie P, Orringer J, Osaki T, Ozog D, Pacheco T, Polder K, Rossi A, Sadick N, Saedi N, Schlessinger J, Sharad J, Shenoy M, Sinclair R, Solish N, Piansay-Soriano M, Sulyman O, Szeimies R, Tanzi E, Taub A, Taylor M, Thomas J, Torezan L, Tosti A, Touma D, Trindade de Almeida A, Vedamurthy M, Viana G, Waldman A, Weinkle S, Weiss R, Poon E, Maher I, Cartee T, Sobanko J, Kirkham J. Development of a Core Outcome Domain Set for Facial Aging. JAMA Dermatology 2026 PMID: 42307924, DOI: 10.1001/jamadermatol.2026.1697.Peer-Reviewed Original ResearchCore outcome setOutcome domainsClinical trialsCochrane Central RegisterCore outcome domain setAdverse eventsFacial agingSystemic adverse eventsCochrane Central Register of Controlled TrialsCentral Register of Controlled TrialsReturn to normal workEfficacy of interventionsDuration of treatment effectRegister of Controlled TrialsConvenience of treatmentControlled clinical trialsRandomized clinical trialsPhysician stakeholdersOutcome setPatient interviewsDelphi surveyDelphi consensusPigmentary changesPatient satisfactionConsensus meeting3 Conventional Photodynamic Therapy for Actinic Keratosis
Alexiades M. 3 Conventional Photodynamic Therapy for Actinic Keratosis. 2026, 20-30. DOI: 10.1016/b978-0-443-10689-7.00003-3.Peer-Reviewed Original ResearchActinic keratosesFederal Drug AdministrationPhotodynamic therapyCell carcinomaTechnique of photodynamic therapyFirst-line treatment optionTreatment of actinic keratosesNon-melanoma skin cancerSquamous cell carcinomaBasal cell carcinomaConventional photodynamic therapyEuropean Medicines AgencyField cancerizationTreatment optionsActinic keratosisSide effectsDrug AdministrationSkin cancerMedicines AgencyNon-melanomaCarcinomaTherapyCancer15 Photodynamic Therapy for Antimicrobial-Resistant Microorganisms and Biofilms
Alexiades M, Tsaoutou K. 15 Photodynamic Therapy for Antimicrobial-Resistant Microorganisms and Biofilms. 2026, 159-171. DOI: 10.1016/b978-0-443-10689-7.00015-x.Peer-Reviewed Original ResearchMethicillin-resistant Staphylococcus aureusPhotodynamic therapyEffective treatmentTreatment of resistant infectionsAntimicrobial-resistant microorganismsAntibiotic-resistant microorganismsAntimicrobial-resistantResistant infectionsTherapeutic approachesInfectious disease managementBiofilmTherapyInfectionMicroorganismsDisease managementPhotodynamic13 Photodynamic Photorejuvenation
Alexiades M. 13 Photodynamic Photorejuvenation. 2026, 139-148. DOI: 10.1016/b978-0-443-10689-7.00013-6.Peer-Reviewed Original Research
2025
Consensus Statement on the Prevention and Management of Complications of Fully Ablative Laser Resurfacing of the Face
Kang B, Cohen J, Geronemus R, Kilmer S, Ross E, Tanzi E, Waibel J, Wong B, Alam M, Alexiades M, Arndt K, Avram M, Bhatia A, Biesman B, Bloom J, Burns A, Chan H, DiGiorgio C, Dover J, Fathizadeh S, Esteves S, Gold M, Goldberg G, Haedersdal M, Hoss E, Ibrahimi O, Jalian H, Kelly K, Manuskiatti W, Marks L, Munavalli G, Pozner J, Robb C, Rossi A, Saedi N, Shumaker P, Stankiewicz K, Wanner M, Wu D, Wulkan A, Ortiz A. Consensus Statement on the Prevention and Management of Complications of Fully Ablative Laser Resurfacing of the Face. Lasers In Surgery And Medicine 2025, 57: 477-489. PMID: 40495549, DOI: 10.1002/lsm.70035.Peer-Reviewed Original ResearchAblative laser resurfacingLaser resurfacingAdverse eventsPostoperative careConsensus statementPlastic surgeryManagement of adverse eventsContraindications to treatmentManagement of infectionsConsensus meetingManagement of complicationsExpert clinical experienceManagement of scarsInternational consensus statementFacial plastic surgeryIntraoperative precautionsPatient selectionOculoplastic surgerySurgeryClinical experiencePreoperative careLaser surgeonVirtual consensus meetingSystematic reviewDraft statement
2024
Introduction 2025 Special Dermatology Plastic Surgery Issue
Alexiades M. Introduction 2025 Special Dermatology Plastic Surgery Issue. Lasers In Surgery And Medicine 2024, 57: 7-7. PMID: 39878547, DOI: 10.1002/lsm.23874.Peer-Reviewed Original Research
2023
Skin Resurfacing with Carbon Dioxide Laser
Alexiades M. Skin Resurfacing with Carbon Dioxide Laser. 2023, 1461-1472. DOI: 10.1007/978-3-031-15130-9_131.Peer-Reviewed Original ResearchCO2 laser resurfacingLaser resurfacingAblative CO2 laser resurfacingSkin resurfacingSide effect profileFractional CO2 laser resurfacingRisk of complicationsManagement of complicationsLaser skin resurfacingCarbon dioxide laserClinical efficacyEffect profilePatient selectionPostoperative instructionsGold standardRadiofrequency Microneedling
Alexiades M. Radiofrequency Microneedling. Facial Plastic Surgery Clinics Of North America 2023, 31: 495-502. PMID: 37806682, DOI: 10.1016/j.fsc.2023.06.010.Peer-Reviewed Original ResearchNovel 1726 nm laser demonstrates durable therapeutic outcomes and tolerability for moderate-to-severe acne across skin types
Alexiades M, Kothare A, Goldberg D, Dover J. Novel 1726 nm laser demonstrates durable therapeutic outcomes and tolerability for moderate-to-severe acne across skin types. Journal Of The American Academy Of Dermatology 2023, 89: 703-710. PMID: 37328000, DOI: 10.1016/j.jaad.2023.05.085.Peer-Reviewed Original ResearchConceptsSevere acneSkin typeTherapeutic outcomesSerious adverse eventsSevere facial acneSignificant side effectsPercentage of subjectsFitzpatrick skin typeLaser treatmentInstitutional review boardOral isotretinoinAdverse eventsSystemic antibioticsTopical therapyInflammatory lesionsHormonal agentsFacial acneAcne managementPosttreatment improvementSide effectsAlternative treatmentControl groupInvestigational deviceAcneReview boardA Randomized, Multicenter, Evaluator-blind Study to Evaluate the Safety and Effectiveness of VYC-12L Treatment for Skin Quality Improvements
Alexiades M, Palm M, Kaufman-Janette J, Papel I, Cross S, Abrams S, Chawla S. A Randomized, Multicenter, Evaluator-blind Study to Evaluate the Safety and Effectiveness of VYC-12L Treatment for Skin Quality Improvements. Dermatologic Surgery 2023, 49: 682-688. PMID: 37163665, PMCID: PMC10292578, DOI: 10.1097/dss.0000000000003802.Peer-Reviewed Original Research